<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03531879</url>
  </required_header>
  <id_info>
    <org_study_id>17.15.NRC</org_study_id>
    <nct_id>NCT03531879</nct_id>
  </id_info>
  <brief_title>ARROW:identificAtion of postpRandial biomaRkers tOWards Cardiovascular Prevention</brief_title>
  <official_title>ARROW: identificAtion of postpRandial biomaRkers tOWards Cardiovascular Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Singapore Institute for Clinical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart Centre Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to better understand the association between the postprandial
      biomarker responses after a food challenge with the development of cardiovascular diseases in
      healthy subjects
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 20, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the kinetics of postprandial biomarkers between two groups of healthy subjects with and without subclinical atherosclerosis</measure>
    <time_frame>Within 28 days from enrollment</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>subject with plaques and without plaques</arm_group_label>
    <description>Subject with plaques and without plaques</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be performed in 100 Chinese subjects at low risk of developing
        cardiovascular diseases, as defined by the Framingham Heart Study Coronary Heart Disease
        10-year risk score with or without subclinical atherosclerosis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Willing and able to sign written informed consent in English or Chinese prior to trial
             entry

          2. 40-54 years old

          3. Both male and female subjects

          4. Chinese ethnic group (having both grandparents Chinese)

          5. Low Framingham risk of CHD (&lt;10%)

          6. Apparently healthy (i.e. no chronic or ongoing acute disease), based on investigator's
             clinical judgement

        Exclusion Criteria:

          1. Food allergy to any of the constituents of the meal challenge (milk proteins, lactose,
             soy).

          2. Subjects not willing or not able to comply with scheduled visits and the requirements
             of the study protocol.

          3. Contraindication to MRI

          4. Pregnant or lactating women based on investigator's clinical judgement.

          5. Morbid obesity (BMI ≥ 40 kg/m2).

          6. Previous myocardial infarction (MI). This will include ST-elevation MI (STEMI) and
             non-ST-elevation MI (NSTEMI).

          7. Known coronary artery disease - prior coronary revascularization.

          8. Known documented peripheral arterial disease.

          9. Previous stroke (defined as new focal neurological deficit persisting more than
             24hours).

         10. Use of anti-hypertensive agents.

         11. Prior history of cancer (excludes pre-cancerous lesions).

         12. Life expectancy less than 1 year.

         13. Known definite diabetes mellitus or on treatment for diabetes mellitus.

         14. Known autoimmune disease or genetic disease.

         15. Known endocrine and metabolic diseases, even on treatment, including hyperlipidemia.

         16. Psychiatric illness.

         17. Asthma or chronic lung disease requiring long term medications or oxygen.

         18. Chronic infective disease, including tuberculosis, hepatitis B and C; and HIV.

         19. Currently participating or having participated in another clinical trial within 4
             weeks prior to trial start (except for Biobank Study and SingHeart).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>54 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

